Furthermore, miR-326 is overexpressed in PBMCs from T1DM patients [12,22], suggesting the involvement of miRNAs in T1DM autoimmunity as they target significant immune modulators—VDR and erythroblastosis virus E26 oncogenic homolog 1 (ETS-1). This evidence concerns the gene ETS1 and type 1 diabetes mellitus.